RE:Disappointing Q1, 2022 EarningsHeadwinds being worked out? We had the better part of June in total lockdown which massacred ACB and Canopy. We held up much better but lost revenue as well with decreased ton no traffic in stores. Millions will be saved in further synergies not to mention Tilray legacy products had they used aphrias processes of manufacturing would have increased our TENTH straight positive EBITA to the tune of millions. I assume those efficient manufacturing processes will be realized to a certain extent this upcoming quarter. Of course distribution is flat since the delta varient has kept the provinces in their decision to reduce cannabis orders. We are number 1 in Germany which just elected a cannabis friendly government. They will legalize recreational marijuana in the coming quarters. We will be ready for that Irwin Simon made sure of that. We are growing our medical revenue and are actively seeking mergers and acquisitions. Tilray is a diversified company which soaked up almost all the recent demand for cannabis. I expect another large LP to fall under our umbrella shortly and another consumer goods packaging acquisition in the United States. With Sweetwater, Manitoba harvest consolidation of the Canadian sector, possible entry into psychedelics (you can be sure Tilray will throw its hat in that ring). We're reaching out across Europe and have weathered Covid 19 drawbacks better then any other company out there. While MSO struggle with cash transactions and high taxes and a federal illegal system. We are growing expanding and diversifying. We grew our revenue by over 45 Percent. It doesn't matter how that happened even if it was through a merger to some degree. It still happend and will continue to happen. We're headed in the right direction.